New generation estrogen receptor-targeted agents in breast cancer: present situation and future prospectives

New generation estrogen receptor-targeted agents in breast cancer: present situation and future prospectives

Endocrine therapy that blocks estrogen receptor signaling has been effective for decades as a primary treatment choice for breast cancer patients expressing the estrogen receptor. However, the issue of drug resistance poses a significant clinical challenge. It is therefore critically important to cr...

Full description

Bibliographic Details
Main Authors:	Jian Min, Xin Liu, Rouming Peng, Chun-Chi Chen, Wei Wang, Rey-Ting Guo
Format:	Article
Language:	English
Published:	Compuscript Ltd 2024-03-01
Series:	Acta Materia Medica
Subjects:	estrogen receptor endocrine-resistant breast cancer serd protac
Online Access:	https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2024-0006

Similar Items

Therapies for the Treatment of Advanced/Metastatic Estrogen Receptor-Positive Breast Cancer: Current Situation and Future Directions
by: Rohan Kalyan Rej, et al.
Published: (2024-01-01)

Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer
by: Niraj Neupane, et al.
Published: (2024-01-01)

Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective
by: Cristina Hernando, et al.
Published: (2021-07-01)

Targeting mutant estrogen receptors
by: Suzanne E Wardell, et al.
Published: (2019-01-01)

Corrigendum: ESR1 fusions and therapeutic resistance in metastatic breast cancer
by: Zsuzsanna Nagy, et al.
Published: (2023-03-01)

ESR1 fusions and therapeutic resistance in metastatic breast cancer
by: Zsuzsanna Nagy, et al.
Published: (2023-01-01)

Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies
by: Rumeysa Ozyurt, et al.
Published: (2022-10-01)

SCR-6852, an oral and highly brain-penetrating estrogen receptor degrader (SERD), effectively shrinks tumors both in intracranial and subcutaneous ER + breast cancer models
by: Feng Zhou, et al.
Published: (2023-08-01)

Genome-wide Estrogen Receptor-α activation is sustained, not cyclical
by: Andrew N Holding, et al.
Published: (2018-11-01)

A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
by: Léa Clusan, et al.
Published: (2023-04-01)

Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence
by: Rocca A, et al.
Published: (2018-08-01)

A Closer Look at Estrogen Receptor Mutations in Breast Cancer and Their Implications for Estrogen and Antiestrogen Responses
by: Léa Clusan, et al.
Published: (2021-01-01)

Editorial: Estrogen receptors in endocrine disorders
by: Tiziana Filardi, et al.
Published: (2023-11-01)

Estrogen-Receptor-Low-Positive Breast Cancer: Pathological and Clinical Perspectives
by: Christina Panagiotis Malainou, et al.
Published: (2023-11-01)

Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
by: Ganesh V Raj, et al.
Published: (2017-08-01)

Roles of estrogens, estrogen-like compounds, and endocrine disruptors in adipocytes
by: Fernando Lizcano
Published: (2022-09-01)

Comprehensive Transcriptomic and Proteomic Analyses Identify a Candidate Gene Set in Cross-Resistance for Endocrine Therapy in Breast Cancer
by: Chung-Liang Li, et al.
Published: (2022-09-01)

Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer
by: Yubo Wang, et al.
Published: (2023-12-01)

Autophagy and senescence facilitate the development of antiestrogen resistance in ER positive breast cancer
by: Michael K. McGrath, et al.
Published: (2024-03-01)

Adjuvant endocrine therapy in patients with estrogen receptor-low positive breast cancer: A prospective cohort study
by: Yuxin Xie, et al.
Published: (2022-12-01)

Unliganded Progesterone Receptor Governs Estrogen Receptor Gene Expression by Regulating DNA Methylation in Breast Cancer Cells
by: Gaetano Verde, et al.
Published: (2018-10-01)

Estrogen Receptors as Molecular Targets of Endocrine Therapy for Glioblastoma
by: Andrea Magali González-Mora, et al.
Published: (2021-11-01)

Clinical implication of low estrogen receptor (ER-low) expression in breast cancer
by: Tomás Reinert, et al.
Published: (2022-11-01)

A Novel <i>Rhipicephalus microplus</i> Estrogen Related Receptor (RmERR), a Molecular and In Silico Characterization of a Potential Protein Binding Estrogen
by: Hugo Aguilar-Díaz, et al.
Published: (2023-09-01)

Predictive Models for Compound Binding to Androgen and Estrogen Receptors Based on Counter-Propagation Artificial Neural Networks
by: Mark Stanojević, et al.
Published: (2023-05-01)

Roles of Estrogen, Estrogen Receptors, and Estrogen-Related Receptors in Skeletal Muscle: Regulation of Mitochondrial Function
by: Kenta Yoh, et al.
Published: (2023-01-01)

Regulatory Interplay between miR-181a-5p and Estrogen Receptor Signaling Cascade in Breast Cancer
by: Rosaria Benedetti, et al.
Published: (2021-02-01)

CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective
by: Fiona H. Zhou, et al.
Published: (2023-03-01)

Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status
by: Downton T, et al.
Published: (2022-09-01)

Expression and function of estrogen receptors and estrogen-related receptors in the brain and their association with Alzheimer’s disease
by: Kaoru Sato, et al.
Published: (2023-07-01)

The Role of Estrogen Receptors in Cardiovascular Disease
by: Laila Aryan, et al.
Published: (2020-06-01)

Level of Combined Estrogen and Progesterone Receptor Expression Determines the Eligibility for Adjuvant Endocrine Therapy in Breast Cancer Patients
by: Jee Hyun Ahn, et al.
Published: (2021-10-01)

Zearalenone, an Estrogenic Mycotoxin, Is an Immunotoxic Compound
by: Isis M. Hueza, et al.
Published: (2014-03-01)

The Peculiar Estrogenicity of Diethyl Phthalate: Modulation of Estrogen Receptor α Activities in the Proliferation of Breast Cancer Cells
by: Marco Fiocchetti, et al.
Published: (2021-09-01)

AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer
by: Amber J. Kiliti, et al.
Published: (2023-08-01)

Role of Estrogen Receptor β, G-Protein Coupled Estrogen Receptor and Estrogen-Related Receptors in Endometrial and Ovarian Cancer
by: Susanne Schüler-Toprak, et al.
Published: (2023-05-01)

Impact of the type of breast cancer on the biodiversity of the vaginal Candida represented by estrogen receptor and its levels
by: Ali Abdul Hussein S. AL-Janabi, et al.
Published: (2023-12-01)

Estrogen-Inducible LncRNA <i>BNAT1</i> Functions as a Modulator for Estrogen Receptor Signaling in Endocrine-Resistant Breast Cancer Cells
by: Kuniko Horie, et al.
Published: (2022-11-01)

Understanding the Role of Estrogen Receptor Status in PRODH/POX-Dependent Apoptosis/Survival in Breast Cancer Cells
by: Sylwia Lewoniewska, et al.
Published: (2021-12-01)

Estrogen receptor targeted contrast agents for molecular magnetic resonance imaging of breast cancer hormonal status
by: Adi ePais, et al.
Published: (2016-04-01)